JP2006527169A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527169A5
JP2006527169A5 JP2006508165A JP2006508165A JP2006527169A5 JP 2006527169 A5 JP2006527169 A5 JP 2006527169A5 JP 2006508165 A JP2006508165 A JP 2006508165A JP 2006508165 A JP2006508165 A JP 2006508165A JP 2006527169 A5 JP2006527169 A5 JP 2006527169A5
Authority
JP
Japan
Prior art keywords
group
polyhydroxyphenol
alkyl group
branched
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006508165A
Other languages
English (en)
Japanese (ja)
Other versions
JP4568813B2 (ja
JP2006527169A (ja
Filing date
Publication date
Priority claimed from EP20030012122 external-priority patent/EP1481669A1/en
Application filed filed Critical
Priority claimed from PCT/EP2004/004898 external-priority patent/WO2004105740A1/en
Publication of JP2006527169A publication Critical patent/JP2006527169A/ja
Publication of JP2006527169A5 publication Critical patent/JP2006527169A5/ja
Application granted granted Critical
Publication of JP4568813B2 publication Critical patent/JP4568813B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006508165A 2003-05-30 2004-05-07 ポリヒドロキシフェノール及びp−セレクチン結合におけるそれらの使用 Expired - Fee Related JP4568813B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20030012122 EP1481669A1 (en) 2003-05-30 2003-05-30 Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
EP04075320 2004-02-03
EP04075545 2004-02-19
EP04075630 2004-02-27
PCT/EP2004/004898 WO2004105740A1 (en) 2003-05-30 2004-05-07 Polyhydroxy phenols and their use in bindng p-selectin

Publications (3)

Publication Number Publication Date
JP2006527169A JP2006527169A (ja) 2006-11-30
JP2006527169A5 true JP2006527169A5 (https=) 2007-06-21
JP4568813B2 JP4568813B2 (ja) 2010-10-27

Family

ID=33494178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006508165A Expired - Fee Related JP4568813B2 (ja) 2003-05-30 2004-05-07 ポリヒドロキシフェノール及びp−セレクチン結合におけるそれらの使用

Country Status (8)

Country Link
US (1) US7273951B2 (https=)
EP (1) EP1651200B1 (https=)
JP (1) JP4568813B2 (https=)
AT (1) ATE418540T1 (https=)
CA (1) CA2527141C (https=)
DE (1) DE602004018647D1 (https=)
ES (1) ES2318287T3 (https=)
WO (1) WO2004105740A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358310B2 (en) * 2007-09-17 2016-06-07 The Curators Of The University Of Missouri EGCG stabilized gold nanoparticles and method for making same
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
FR2893505B1 (fr) * 2005-11-23 2007-12-28 Oreal Dispersion aqueuse d'acide ellagique et son utilisation en cosmetique
CN1837169A (zh) * 2006-03-14 2006-09-27 房学迅 一类能够抑制锌离子金属蛋白酶的化合物
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
JP5006137B2 (ja) * 2007-08-28 2012-08-22 日本合成化学工業株式会社 イソシアノ酢酸アルキルエステル液状組成物およびその保存方法
US8754052B2 (en) 2008-06-26 2014-06-17 Mayo Foundation For Medical Education And Research Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG)
US8030432B2 (en) * 2009-12-10 2011-10-04 The United States Of America As Represented By The Secretary Of The Army Copolymerization of hydroxytyrosol with flavonoids mediated by horseradish peroxidases
US8134020B2 (en) * 2009-12-10 2012-03-13 The United States Of America As Represented By The Secretary Of The Army Polymerization of hydroxytyrosol mediated by horseradish peroxidases
US9427454B2 (en) * 2014-02-26 2016-08-30 Robert den Hoed Method of making liquid olive leaf extract
CN117257785A (zh) * 2023-11-09 2023-12-22 新疆医科大学 没食子酸及其衍生物在制备预防和/或治疗心肌损伤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317561B (en) 1996-09-20 2000-12-06 Howard Foundation Improvements in or relating to food supplements
US6410052B1 (en) 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
JP2001316259A (ja) * 2000-05-01 2001-11-13 Taiyo Kagaku Co Ltd ポリフェノール類製剤
ITRM20010600A1 (it) 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein

Similar Documents

Publication Publication Date Title
Grigoras Drug delivery systems using pullulan, a biocompatible polysaccharide produced by fungal fermentation of starch
Alsaab et al. PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases
Imam et al. Recent advancement in chitosan-based nanoparticles for improved oral bioavailability and bioactivity of phytochemicals: Challenges and perspectives
Sanna et al. Targeted biocompatible nanoparticles for the delivery of (−)-epigallocatechin 3-gallate to prostate cancer cells
JP2006527169A5 (https=)
Liu et al. Platensimycin-encapsulated poly (lactic-co-glycolic acid) and poly (amidoamine) dendrimers nanoparticles with enhanced anti-staphylococcal activity in vivo
JP2012525409A5 (https=)
Arbez-Gindre et al. Dendrimers in Alzheimer’s disease: recent approaches in multi-targeting strategies
CN102307464A (zh) 含有硝基脂肪酸的营养制品
WO2016025745A1 (en) Dendrimer compositions and use in treatment of neurological and cns disorders
Zhang et al. Cinnamaldehyde-contained polymers and their biomedical applications
TW201717941A (zh) 氯喹(chloroquine)及克立咪唑(clemizole)化合物於治療發炎及癌症病況之用途
Silva et al. Green solvents combined with bioactive compounds as delivery systems: present status and future trends
RS60558B1 (sr) Pentaaza makrociklični prstenasti kompleksi koji poseduju oralnu bioraspoloživost
US20170367989A1 (en) Nanoparticles for lipid homeostasis
Jaroszewski et al. Drug delivery systems of betulin and its derivatives: An overview
KR20200142053A (ko) 신경 내분비 종양의 치료에서 이중 표적화를 위한 조성물 및 방법
CN118178688A (zh) 用于恶病质的检测的ct造影剂
JP2011525498A (ja) フラボノリグナンベースの組成物およびその調製方法
Pan et al. Delivery strategies, structural modification, and pharmacological mechanisms of honokiol: a comprehensive review
JP7016853B2 (ja) sGC刺激剤のリンプロドラッグ
CA2527141A1 (en) Polyhydroxy phenols and their use in binding p-selectin
Wu et al. Preparation of betulinic acid galactosylated chitosan nanoparticles and their effect on liver fibrosis
Liu et al. Strategies for solubility and bioavailability enhancement and toxicity reduction of norcantharidin
Christoforou et al. The Ubiquitous Use of Polyethylene Glycol in Pharmaceutical Design and Development: Technological Aspects and Future Perspectives